Condensed Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		3 Months Ended
		Mar. 29, 2019	Mar. 30, 2018
Net sales		$ 790.6	$ 755.3
Cost of sales		455.5	407.8
Gross profit		335.1	347.5
Selling, general and administrative expenses		230.2	211.2
Research and development expenses		85.3	82.0
Restructuring charges, net		4.2	28.2
Operating income	[1]	15.4	26.1
Interest expense		(82.7)	(91.4)
Interest income		1.5	3.2
Other income, net		16.3	4.6
Loss from continuing operations before income taxes		(49.5)	(57.5)
Income tax benefit		(204.7)	(36.6)
Income (loss) from continuing operations		155.2	(20.9)
(Loss) income from discontinued operations, net of income taxes		(0.3)	2.9
Net income (loss)		$ 154.9	$ (18.0)
Basic earnings per share (Note 8):
Income (loss) from continuing operations, per share		$ 1.86	$ (0.24)
Income from discontinued operations, per share		0	0.03
Net income, per share		$ 1.86	$ (0.21)
Basic weighted-averaged shares outstanding (in shares)		83.5	86.1
Diluted earnings per share (Note 8):
Income (loss) from continuing operations, per share		$ 1.83	$ (0.24)
Income from discontinued operations, per share		0	0.03
Net income, per share		$ 1.83	$ (0.21)
Diluted weighted-average shares outstanding (in shares)		84.6	86.1

[1] The amount of operating loss included in the Company's unaudited condensed statement of income for the three months ended March 30, 2018 related to the Sucampo Acquisition was $30.7 million. Included within these results were $9.1 million of amortization associated with intangibles recognized from this acquisition and $15.0 million of expense associated with fair value adjustments of acquired inventory.